Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme

Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells

(2014) T.-S. Lu et al.   JOURNAL OF IMMUNOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD

(2012) Jing Han et al.   CELL

Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model

(2012) Pedro Cruz Duarte et al.   EXPERIMENTAL NEUROLOGY

Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats

(2012) K. Yaragudri Vinod et al.   PLoS One

Prospects for cannabinoid therapies in basal ganglia disorders

(2011) Javier Fernández-Ruiz et al.   BRITISH JOURNAL OF PHARMACOLOGY

BDNF control of adult SVZ neurogenesis

(2011) Kevin G. Bath et al.   DEVELOPMENTAL PSYCHOBIOLOGY

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

(2011) Onintza Sagredo et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

(2011) Eliezer Masliah et al.   PLoS One

Location-Specific Epigenetic Regulation of the Metallothionein 3 Gene in Esophageal Adenocarcinomas

(2011) DunFa Peng et al.   PLoS One

The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain

(2010) Maria Beatriz Goncalves et al.   BRITISH JOURNAL OF PHARMACOLOGY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

(2010) Javier Fernández-Ruiz et al.   CNS Neuroscience & Therapeutics

The endocannabinoid system in gp120-mediated insults and HIV-associated dementia

(2010) Monica Bari et al.   EXPERIMENTAL NEUROLOGY

The endocannabinoid system as a target for the treatment of neuronal damage

(2010) Javier Fernández-Ruiz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Arachidonic Acid Drives Postnatal Neurogenesis and Elicits a Beneficial Effect on Prepulse Inhibition, a Biological Trait of Psychiatric Illnesses

(2009) Motoko Maekawa et al.   PLoS One

Cannabinoids, multiple sclerosis and neuroprotection

(2009) Eva de Lago et al.   Expert Review of Clinical Pharmacology

Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats

(2008) Marylou V Solbrig et al.   JOURNAL OF NEUROVIROLOGY

Role of CB2 receptors in neuroprotective effects of cannabinoids

(2008) Javier Fernández-Ruiz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner

(2008) Maria Beatriz Goncalves et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Prostamides (prostaglandin-ethanolamides) and their pharmacology

(2007) D F Woodward et al.   BRITISH JOURNAL OF PHARMACOLOGY

Mutant α-synuclein exacerbates age-related decrease of neurogenesis

(2007) Beate Winner et al.   NEUROBIOLOGY OF AGING